Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...

Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most ...

Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, doctors said he's essentially "cured" thanks to gene therapy treatment at ...

The American Journal of Managed Care® ( AJMC®) hosted its annual event, Patient Centered-Oncology Care (PCOC), on September ...

Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA approved it for that use. But it was a long road. First, he had to undergo ...

The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is projected to ...

Labroots and the Cell & Gene Therapy planning committee are thrilled to announce the 2nd Annual Cell & Gene Therapy Virtual Event Series, live on October 15, 2025. This free, interactive event brings ...

The search for gene therapies to treat rheumatoid arthritis (RA) has moved in fits and starts over the past two decades, with trials starting and stopping, and their focus shifting to osteoarthritis ...

Miriya Nurse, 16, spent months in the hospital undergoing a groundbreaking treatment that cured her rare blood disorder.

TOMI Environmental Solutions, Inc.® ('TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, ...

Labroots is pleased to announce the 2nd annual event in the Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Therapy planning committee will invite ...